Recombinant Human Interferon Alpha-2b (Shenyang Pharmaceutical University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Human Interferon Alpha-2b (Shenyang Pharmaceutical University)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionInterferon alpha 2 ligand
TargetsInterferon alpha-2
Therapy Area/IndicationsNeoplasmsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenyang Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsNeoplasmsHepatitis CHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A